Gyre Therapeutics (GYRE) Goodwill & Intangibles (2010 - 2026)
Gyre Therapeutics (GYRE) reported Goodwill & Intangibles of $5.8 million for Q1 2026, up 4.75% year-over-year from $5.6 million in Q1 2025, and up 1.62% quarter-over-quarter from $5.8 million in Q4 2025.
Gyre Therapeutics (GYRE) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has 10 years of Goodwill & Intangibles data on file, last reported at $5.8 million in Q1 2026.
- Goodwill & Intangibles for Q1 2026 came in at $5.8 million, up 4.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.8 million (up 4.75% YoY), and the FY2025 annual result was $5.8 million, up 2006.23% from the prior year.
- Goodwill & Intangibles advanced to $5.8 million in Q1 2026 per GYRE's latest filing, from $5.8 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $5.8 million in Q1 2026 and troughed at $273000.0 in Q4 2023.
- A 5-year average of $2.8 million and a median of $611000.0 in 2024 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2023 and 2025: Goodwill & Intangibles dropped 8.08% in 2023, then jumped 2006.23% in 2025.
- A 5-year view of Goodwill & Intangibles shows it stood at $297000.0 in 2022, then decreased by 8.08% to $273000.0 in 2023, then changed by 0.0% to $273000.0 in 2024, then jumped by 2006.23% to $5.8 million in 2025, then gained by 1.62% to $5.8 million in 2026.
- Business Quant data shows GYRE's Goodwill & Intangibles at $5.8 million in Q1 2026, $5.8 million in Q4 2025, and $5.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Gyre Therapeutics | 554.75 Mn | 540.62 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.84 Mn |
| Dec 31, 2025 | 5.75 Mn |
| Sep 30, 2025 | 5.69 Mn |
| Jun 30, 2025 | 5.63 Mn |
| Mar 31, 2025 | 5.58 Mn |
| Dec 31, 2024 | 273,000.00 |
| Sep 30, 2024 | 611,000.00 |
| Jun 30, 2024 | 598,000.00 |
| Mar 31, 2024 | 601,000.00 |
| Dec 31, 2023 | 273,000.00 |
| Dec 31, 2022 | 297,000.00 |
| Dec 31, 2014 | 296,000.00 |
| Jun 30, 2014 | 89,000.00 |
| Mar 31, 2014 | 93,000.00 |
| Dec 31, 2013 | 97,000.00 |
| Sep 30, 2013 | 102,000.00 |
| Jun 30, 2013 | 106,000.00 |
| Mar 31, 2013 | 110,000.00 |
| Dec 31, 2012 | 296,000.00 |
| Sep 30, 2012 | 119,000.00 |